Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000174583 | SCV000225903 | uncertain significance | not provided | 2015-04-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001084912 | SCV001121630 | likely benign | Cohen syndrome | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002399628 | SCV002711836 | likely benign | Inborn genetic diseases | 2018-03-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003895183 | SCV004712991 | likely benign | VPS13B-related disorder | 2022-08-02 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Natera, |
RCV001084912 | SCV001456245 | likely benign | Cohen syndrome | 2020-06-05 | no assertion criteria provided | clinical testing |